ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and ...
Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80mg, 100 mg, and 140 mg are bioequivalent to Sprycel Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, of Bristol-Myers Squibb Company, and indicated fo ...
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Cycle Pharmaceuticals (Cycle Pharma) has entered into an exclusive U.S. commercialization agreement with Handa Therapeutics, LLC (Handa), for PHYRAGO, an ...
Chronic myeloid leukemia may seem to appear suddenly, but new research shows it begins years before diagnosis with an explosive surge of growth. Scientists tracked how a single genetic accident—the ...
Nilotinib is indicated for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia in pediatric patients. Nilotinib capsules are available in 150 mg and 200 mg strengths. Each of ...
Chronic myeloid leukaemia (CML) is a blood cancer marked by excessive production of myeloid cells (immune cells derived from the bone marrow). Unlike most cancers, which require multiple genetic ‘hits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results